9.2 Neonatal Seizures & Intraventricular Hemorrhage (IVH)

Neonatal Seizures & Intraventricular Hemorrhage (IVH)

Neurological emergencies during neonatal transport require rapid, disciplined assessment and intervention. Seizures represent the most frequent manifestation of central nervous system (CNS) injury in the newborn, yet their clinical signs are subtle and easily missed. Simultaneously, premature infants born before 32 weeks of gestation possess extreme anatomical fragility of the cerebral germinal matrix. Mechanical vibration, acceleration forces, and physiological instability encountered during transport can trigger or worsen catastrophic intraventricular hemorrhage (IVH). Implementing standardized neuroprotective bundles and antiepileptic protocols is paramount to preserving long-term neurological potential.

---

Neonatal Seizure Semiology: Neocortical Immaturity & Classification

Unlike older pediatric patients, neonates rarely present with generalized, synchronized tonic-clonic seizures. This unique clinical presentation stems from developmental neurobiology:

1. Incomplete Synaptogenesis & Myelination: The neonatal neocortex has deficient dendritic arborization, immature synaptic connectivity, and incomplete axonal myelination, preventing the synchronized propagation of electrical discharge across cerebral hemispheres.
2. Depolarizing GABA Paradox: In the immature brain, expression of the Na+-K+-2Cl- cotransporter 1 (NKCC1) is high, whereas the potassium-chloride exporter (KCC2) is low. This maintains a high intracellular chloride concentration. When gamma-aminobutyric acid (GABA) binds to GABA-A receptors, chloride flows out of the neuron rather than in, causing membrane depolarization and neuronal excitation rather than inhibition.

Clinical Classification of Neonatal Seizures

• Subtle Seizures (50% – 65% of all neonatal seizures): Most common in both term and preterm infants. Signs include:
  • Ocular: Sustained tonic horizontal eye deviation, periodic rapid eye blinking, repetitive flutter, or fixed staring.
  • Oral-buccal-lingual: Repetitive lip smacking, tongue protrusion/thrusting, chewing, sucking, or drooling.
  • Motor / Limb movements: Rhythmic boxing, swimming movements of the arms, pedaling, or bicycling motions of the lower extremities.
  • Autonomic / Respiratory: Paroxysmal apnea, episodic hypertension, pupillary dilation, or tachycardia. Notably, seizure-induced apnea is typically accompanied by tachycardia or normal heart rate, whereas primary central apnea of prematurity is almost universally accompanied by progressive bradycardia.
• Clonic Seizures: Rhythmic, slow jerking movements (1 to 3 contractions per second). May be focal (confined to one limb) or multifocal (migrating irregularly from one body part to another). Unaffected by physical repositioning.
• Tonic Seizures: Sustained, rigid posturing of an extremity or the trunk. Can be focal or generalized (simulating decerebrate or decorticate posturing).
• Myoclonic Seizures: Rapid, non-rhythmic, lightning-fast twitching of flexor muscle groups. Often indicates severe diffuse cortical injury.
• Electrographic-Only (Subclinical) Seizures: Electrical seizure discharges on amplitude-integrated EEG (aEEG) or continuous EEG without visible motor activity. Extremely common following anticonvulsant administration (electroclinical dissociation) and in neonates undergoing therapeutic hypothermia.

Differentiating Jitteriness vs. True Seizures

Jitteriness (tremulousness) is a benign, involuntary, rhythmic motor disturbance common in neonates with hypoglycemia, hypocalcemia, mild encephalopathy, or neonatal opioid withdrawal. Distinguishing jitteriness from clonic seizures is an essential clinical competency.

---

Transport Pharmacotherapy for Neonatal Seizures

Seizures dramatically increase cerebral metabolic rate, oxygen consumption, and glucose utilization while impairing cerebral autoregulation. Prompt pharmacological termination is mandatory.

1. First-Line Therapy: Phenobarbital

Phenobarbital remains the gold standard, trial-validated first-line antiepileptic in neonatal transport.

• Mechanism: Binds to GABA-A receptors, enhancing chloride influx and suppressing presynaptic glutamate release.
• Loading Dose: 20 mg/kg IV administered slowly over 10 to 15 minutes.
• Incremental Dosing: If seizures persist 15 minutes after completion of the initial infusion, administer additional doses of 5 to 10 mg/kg IV every 15 minutes up to a maximum cumulative loading dose of 40 mg/kg.
• Critical Transport Monitoring: Phenobarbital causes dose-dependent central respiratory depression and systemic vasodilation/myocardial depression (partially mediated by its propylene glycol solvent). Transport clinicians must ensure immediate endotracheal intubation capability and have isotonic crystalloid boluses and inotropes (epinephrine/dopamine) instantly accessible.

2. Second-Line Therapies

• Levetiracetam (Keppra):
  • Mechanism: Binds to synaptic vesicle protein SV2A, inhibiting presynaptic calcium-dependent exocytosis of excitatory neurotransmitters.
  • Dose: 40 to 60 mg/kg IV infused over 10 to 15 minutes.
  • Advantages: Lacks cardiovascular and respiratory depressant effects, possesses minimal drug interactions, and does not exhibit neurotoxicity in animal models.
• Fosphenytoin:
  • Mechanism: Water-soluble pro-drug of phenytoin; blocks voltage-gated neuronal sodium channels.
  • Dose: 20 mg PE (phenytoin equivalents)/kg IV administered at a rate not exceeding 1 to 2 mg PE/kg/min.
  • Transport Caution: Requires continuous cardiac rhythm monitoring. Rapid administration triggers severe cardiac arrhythmias, QTc prolongation, and vasodilation.

3. Refractory Neonatal Status Epilepticus: Pyridoxine Trial

In infants with intractable seizures refractory to phenobarbital and second-line anticonvulsants, consider pyridoxine-dependent epilepsy (an autosomal recessive mutation of ALDH7A1 causing antiquitin deficiency and secondary vitamin B6 depletion).

• Diagnostic Protocol: Administer Pyridoxine (Vitamin B6) 100 mg IV under continuous cardiorespiratory and aEEG monitoring.
• Clinical Response: Immediate cessation of seizures within minutes confirms the diagnosis.
• Transport Warning: Intravenous pyridoxine administration frequently triggers sudden, profound hypotonia, apnea, and cardiovascular collapse. The transport specialist must secure the infant's airway and establish invasive mechanical ventilation prior to administration.

---

Pathophysiology of Intraventricular Hemorrhage (IVH)

Intraventricular hemorrhage is primarily a disease of preterm infants born at $<32$ weeks of gestation (and especially $<28$ weeks or birth weight $<1,000$ g). The anatomical ground zero for IVH is the subependymal germinal matrix.

Germinal Matrix Vulnerability

• Histology: The germinal matrix is a gelatinous, highly cellular, highly vascularized embryonic zone overlying the head of the caudate nucleus that generates cortical neurons and glial cells. It reaches peak prominence at 24 to 28 weeks and involutes completely by 34 to 36 weeks.
• Fragile Microvasculature: The capillary network of the germinal matrix consists of large, irregular endothelial vessels that lack basement membrane collagen, muscular coats, and surrounding pericyte support. It is located at an arterial watershed zone between deep striate and choroidal arteries, with venous drainage emptying into the deep Galenic venous system through an acute U-shaped hairpin loop, creating high baseline resistance to venous outflow.
• Loss of Autoregulation (Pressure-Passive Circulation): Ill preterm infants exhibit pressure-passive cerebral circulation. Under normal circumstances, cerebral arterioles constrict in response to high systemic pressure and dilate during hypotension to maintain steady cerebral blood flow. In sick premature infants, autoregulation is abolished: any surge in arterial blood pressure or central venous pressure transmits directly into the fragile germinal matrix capillaries, causing rupture and hemorrhage.

---

Papile Grading System for IVH

Intraventricular hemorrhage is classified into four grades based on cranial ultrasonography findings:

Note on Grade IV (PVHI): Modern neuropathology recognizes that Grade IV is not simply blood spilling out of the ventricle into tissue, but rather a periventricular hemorrhagic venous infarction (PVHI). Large intraventricular clots compress the terminal and subependymal medullary veins, blocking deep cerebral venous drainage and causing massive ischemic and hemorrhagic necrosis of the periventricular white matter.

---

In-Transit IVH Triggers & The Transport Neuroprotective Bundle

Physical and physiological stressors during interfacility transport can trigger de novo germinal matrix rupture or extend a Grade I hemorrhage into a fatal Grade IV PVHI. The transport team must eliminate every preventable trigger.

Dangerous In-Transit Triggers

1. Fluctuations in Cerebral Blood Flow: Rapid systemic blood pressure swings driven by pain, crying, tracheal suctioning, or aggressive inotrope titration.
2. Rapid Hypertonic Infusions: Rapid pushes of Sodium Bicarbonate (osmolality $\sim 2,000 \text{ mOsm/L}$) or undiluted tromethamine (THAM) pull fluid out of brain tissue into intravascular spaces, causing rapid brain shrinkage, mechanical traction on fragile veins, acute surges in blood volume, and capillary rupture.
3. Rapid Fluid Boluses: Pushing 10 or 20 mL/kg saline boluses over minutes spikes systemic arterial pressure and ruptures the germinal matrix.
4. Hypocarbia and Hypercarbia:
   • Severe hypocarbia ($PaCO2 < 35 \text{ mmHg}$) induces intense cerebral vasoconstriction, causing periventricular white matter ischemia.
   • Acute hypercarbia ($PaCO2 > 60-65 \text{ mmHg}$) induces profound cerebral vasodilation, increasing cerebral blood flow and capillary transmural pressure.
5. Impaired Cerebral Venous Drainage: Twisting or flexing the neck compresses the internal jugular veins, elevating intracranial venous pressure. Pneumothoraces and high mean airway pressures ($Paw$) also back up venous blood from the superior vena cava into the head.

The Transport Neuroprotective Bundle

• Neutral Midline Head Positioning: Position the neonate's head strictly in the midline (neutral position) using foam rolls or gel positioners. Avoid neck flexion, extreme hyperextension, or lateral rotation greater than 45 degrees, which obstruct jugular venous return.
• Head-of-Bed Elevation (15° to 30°): Elevate the head of the transport isolette mattress by 15 to 30 degrees to optimize intracranial venous drainage and reduce intracranial pressure.
• Controlled Slow Fluid Administration: When volume expansion is clinically indicated for hypovolemic shock, administer isotonic normal saline at 10 mL/kg slowly over 30 to 60 minutes via an infusion pump. Never deliver rapid manual syringe pushes.
• Strict Normocarbia Titration: Target a $PaCO2$ between 45 and 55 mmHg (in premature infants receiving gentle mechanical ventilation). Avoid overventilation ($PaCO2 < 40 \text{ mmHg}$) and rapid blood gas fluctuations.
• Minimal Handling & Clustered Care: Eliminate non-essential interventions. Suction endotracheal tubes only for clear clinical indications (secretions, acute desaturation, chest rise loss) rather than routine schedules. Apply topical lidocaine or gentle oral sucrose/analgesia before painful procedures.